Herpes Virus Hominis Neutralization Antisera Suppliers
www.zeussci.com | Send Inquiry | Phone: +1-(908)-526-3744
FDA Registration: 2242436 Year Established: 1976 Annual Revenues: USD 10-25 Million Employee Count: ~60 Quality: ISO 9001 Certified
Products: Anti-MPO ANCA, Anti-Gliadin (Ab), ANA (Antinuclear antibodies), Rheumatoid Factor (RF), Anti-Gliadin (Ab) IgG Kit, Anti-Gliadin (Ab) IgA Kit, ...
Zeus Scientific, Inc. is a global healthcare company that provides diagnostic products for the enhancement of patient care. We are an ISO 9001 certified company. We offer products like Athena, elisa & more...
Phone: +39-(6)-9195735
Products: C-Reactive Protein Test System (FDA Code: DCN), Rheumatoid Factor Test System (FDA Code: DHR), 2 Herpesvirus Hominis 1 CF Antigen (FDA Code: GQN), 2 Herpesvirus Hominis 1 Cf Antisera (FDA Code: GQO), Adenovirus 1-33 CF Antigen (FDA Code: GOD), Adenovirus 1-33 CF Antisera (FDA Code: GOA), ...
Alfa Biotech Spa specializes in offering vaccines, blood products and diagnostic products for laboratory & medical use. more...
Herpes simplex virus serological assays are devices that consist of antigens and antisera used in various serological tests to identify antibodies to herpes simplex virus in serum. Additionally, some of the assays consist of herpes simplex virus antisera conjugated with a fluorescent dye (immunofluorescent assays) used to identify herpes simplex virus directly from clinical specimens or tissue culture isolates derived from clinical specimens. The identification aids in the diagnosis of diseases caused by herpes simplex viruses and provides epidemiological information on these diseases. Herpes simplex viral infections range from common and mild lesions of the skin and mucous membranes to a severe form of encephalitis (inflammation of the brain). Neonatal herpes virus infections range from a mild infection to a severe generalized disease with a fatal outcome.
Classification. Class II (special controls). The device is classified as class II (special controls). The special control for the device is FDA's revised guidance document entitled "Class II Special Controls Guidance Document: Herpes Simplex Virus Types 1 and 2 Serological Assays." For availability of the guidance revised document, see 866.1(e).
